Cargando…

Legumain Promotes Atherosclerotic Vascular Remodeling

Legumain, a recently discovered cysteine protease, is increased in both carotid plaques and plasma of patients with carotid atherosclerosis. Legumain increases the migration of human monocytes and human umbilical vein endothelial cells (HUVECs). However, the causal relationship between legumain and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ozawa, Nana, Sato, Yuki, Mori, Yukari, Masuda, Hiroko, Yamane, Mao, Yamamoto, Yuka, Shirai, Remina, Watanabe, Rena, Sato, Kengo, Mori, Yusaku, Hirano, Tsutomu, Watanabe, Takuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539540/ https://www.ncbi.nlm.nih.gov/pubmed/31060209 http://dx.doi.org/10.3390/ijms20092195

Ejemplares similares

β-Endorphin Mediates the Development and Instability of Atherosclerotic Plaques
por: Okano, Taisuke, et al.
Publicado: (2020)

Adropin Contributes to Anti-Atherosclerosis by Suppressing Monocyte-Endothelial Cell Adhesion and Smooth Muscle Cell Proliferation
por: Sato, Kengo, et al.
Publicado: (2018)

Vasoprotective Effects of Urocortin 1 against Atherosclerosis In Vitro and In Vivo
por: Hasegawa, Akinori, et al.
Publicado: (2014)

Anti-Atherogenic Effects of Vaspin on Human Aortic Smooth Muscle Cell/Macrophage Responses and Hyperlipidemic Mouse Plaque Phenotype
por: Sato, Kengo, et al.
Publicado: (2018)

Potent Vasoconstrictor Kisspeptin‐10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist
por: Sato, Kengo, et al.
Publicado: (2017)

Endogenous Bioactive Peptides as Potential Biomarkers for Atherosclerotic Coronary Heart Disease
por: Watanabe, Takuya, et al.
Publicado: (2012)

Salusins: Potential Use as a Biomarker for Atherosclerotic Cardiovascular Diseases
por: Sato, Kengo, et al.
Publicado: (2013)

Neopterin Counters Vascular Inflammation and Atherosclerosis
por: Shirai, Remina, et al.
Publicado: (2018)

Atheroprotective Effects of Tumor Necrosis Factor–Stimulated Gene-6
por: Watanabe, Rena, et al.
Publicado: (2016)

Emerging Roles of Tumor Necrosis Factor-Stimulated Gene-6 in the Pathophysiology and Treatment of Atherosclerosis
por: Watanabe, Rena, et al.
Publicado: (2018)

GIP as a Potential Therapeutic Target for Atherosclerotic Cardiovascular Disease–A Systematic Review
por: Mori, Yusaku, et al.
Publicado: (2020)

Amelioration of Hyperglycemia with a Sodium-Glucose Cotransporter 2 Inhibitor Prevents Macrophage-Driven Atherosclerosis through Macrophage Foam Cell Formation Suppression in Type 1 and Type 2 Diabetic Mice
por: Terasaki, Michishige, et al.
Publicado: (2015)

Anti‐atherogenic and anti‐inflammatory properties of glucagon‐like peptide‐1, glucose‐dependent insulinotropic polypepide, and dipeptidyl peptidase‐4 inhibitors in experimental animals
por: Hirano, Tsutomu, et al.
Publicado: (2016)

Secretion of Legumain Increases in Conditioned Medium from DJ-1-Knockout Cells and in Serum from DJ-1-Knockout Mice
por: Yamane, Takuya, et al.
Publicado: (2018)

Combination Therapy with a Sodium-Glucose Cotransporter 2 Inhibitor and a Dipeptidyl Peptidase-4 Inhibitor Additively Suppresses Macrophage Foam Cell Formation and Atherosclerosis in Diabetic Mice
por: Terasaki, Michishige, et al.
Publicado: (2017)

Protease activity of legumain is inhibited by an increase of cystatin E/M in the DJ-1-knockout mouse spleen, cerebrum and heart
por: Yamane, Takuya, et al.
Publicado: (2017)

Nuclear Legumain Activity in Colorectal Cancer
por: Haugen, Mads H., et al.
Publicado: (2013)

Prognostic value of legumain in uveal melanoma
por: WU, TONG, et al.
Publicado: (2016)

Nesfatin-1 suppresses peripheral arterial remodeling without elevating blood pressure in mice
por: Mori, Yusaku, et al.
Publicado: (2019)

A Dipeptidyl Peptidase-4 Inhibitor Suppresses Macrophage Foam Cell Formation in Diabetic db/db Mice and Type 2 Diabetes Patients
por: Terasaki, Michishige, et al.
Publicado: (2018)

Correction: Nuclear Legumain Activity in Colorectal Cancer
por: Haugen, Mads H., et al.
Publicado: (2013)

The Mammalian Cysteine Protease Legumain in Health and Disease
por: Solberg, Rigmor, et al.
Publicado: (2022)

Hypomyelinating Leukodystrophy 10 (HLD10)-Associated Mutations of PYCR2 Form Large Size Mitochondria, Inhibiting Oligodendroglial Cell Morphological Differentiation
por: Torii, Tomohiro, et al.
Publicado: (2022)

Expression of Legumain Correlates with Prognosis and Metastasis in Gastric Carcinoma
por: Guo, Pengtao, et al.
Publicado: (2013)

Legumain Functions as a Transient TrkB Sheddase
por: Holzner, Christoph, et al.
Publicado: (2023)

Hypoxia-driven protease legumain promotes immunosuppression in glioblastoma
por: Pang, Lizhi, et al.
Publicado: (2023)

Preventive Effect of Dipeptidyl Peptidase-4 Inhibitor on Atherosclerosis Is Mainly Attributable to Incretin's Actions in Nondiabetic and Diabetic Apolipoprotein E-Null Mice
por: Terasaki, Michishige, et al.
Publicado: (2013)

Pheochromocytoma presenting with severe hyperglycemia and metabolic acidosis following intra-articular glucocorticoid administration: a case report
por: Tomoyasu, Masako, et al.
Publicado: (2019)

Simvastatin Inhibits Glucose Metabolism and Legumain Activity in Human Myotubes
por: Smith, Robert, et al.
Publicado: (2014)

Structure and Mechanism of an Aspartimide-Dependent Peptide Ligase in Human Legumain**
por: Dall, Elfriede, et al.
Publicado: (2015)

High Plasma Levels of Legumain in Patients with Complex Coronary Lesions
por: Umei, Tomohiko C., et al.
Publicado: (2020)

Knockdown of Legumain Suppresses Cervical Cancer Cell Migration and Invasion
por: Meng, Fei, et al.
Publicado: (2016)

Cystatin E/M suppresses legumain activity and invasion of human melanoma
por: Briggs, Jon J, et al.
Publicado: (2010)

Correction: Simvastatin Inhibits Glucose Metabolism and Legumain Activity in Human Myotubes
Publicado: (2014)

An infection-induced oxidation site regulates legumain processing and tumor growth
por: Kovalyova, Yekaterina, et al.
Publicado: (2022)

Roles of Species-Specific Legumains in Pathogenicity of the Pinewood Nematode Bursaphelenchus xylophilus
por: Zhang, Xi, et al.
Publicado: (2022)

Legumain Activity Is Controlled by Extended Active Site Residues and Substrate Conformation
por: Elamin, Tasneem, et al.
Publicado: (2022)

M2 tumour-associated macrophages contribute to tumour progression via legumain remodelling the extracellular matrix in diffuse large B cell lymphoma
por: Shen, Long, et al.
Publicado: (2016)

New Insights into Risk Genes and Their Candidates in Multiple Sclerosis
por: Shirai, Remina, et al.
Publicado: (2022)

Luseogliflozin attenuates neointimal hyperplasia after wire injury in high-fat diet-fed mice via inhibition of perivascular adipose tissue remodeling
por: Mori, Yusaku, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o8jtm5k5e4uprhg3507je85260